Project Grant R01HL177837
Award Date
6/1/25
Completion Date
3/31/29
Dollars Obligated
$740K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This federal Project Grant award, valued at $773,916.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund research to create and validate a tool to calculate the contribution of each bronchopulmonary dysplasia (BPD) phenotype to elevated work of breathing in premature neonates. The project aims to identify the specific components of work of breathing (elastic, resistive) related to BPD...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,415,112 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the Board of Regents of the University of Nebraska to evaluate a telehealth-delivered adaptive intervention for persons newly diagnosed with obstructive sleep apnea (OSA) that promotes continuous positive airway pressure (CPAP) therapy adherence and improves health outcomes. The project aims to: 1) compare the effects of motivational enhancement, device...
This $151,578 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the role of nocturnal hypoxemia and hypoxia-inducible factor 1-alpha (HIF1A) in skeletal muscle protein homeostasis and sarcopenia in chronic obstructive pulmonary disease (COPD). The research, conducted by the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, aims to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $421,800.00 to Midwestern University to explore the effects of chronic intermittent hypoxia on cholinergic modulation at hypoglossal motoneurons. The project will use immunofluorescence and electrophysiology techniques to evaluate neuroanatomical and functional changes in cholinergic signaling at hypoglossal motoneurons in mice...
This $696,470 Project Grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports a research project investigating the impact of prenatal maternal sleep on pathways related to offspring cardiovascular disease (CVD) risk. Specifically, the project will examine how prenatal maternal sleep trajectories predict maternal biological processes (stress, inflammation), child biological processes (growth,...
This National Heart, Lung, and Blood Institute (NHLBI) Cardiovascular Diseases Research Program (CFDA 93.837) project grant provides $162,728 to the University of California, San Diego (UCSD) for the project period of January 1, 2025 to August 15, 2027. The grant will fund a mechanistic study to evaluate the underlying cardiovascular impacts of comorbid obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), referred to as overlap syndrome (OVS). The research aims to...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $5,715,866 to develop novel, transformative therapies that reduce the burden of morbidity and mortality from progressive pulmonary fibrosis (PF). The 5-year project, awarded on September 17, 2024, aims to re-shape understanding of the natural history of PF by investigating transcriptomic, genetic, epigenetic, metabolic, and environmental factors that contribute to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $744,305 to the Rector & Visitors of the University of Virginia (UVA) to conduct research on the molecular physiology of PHOX2B-expressing neurons in the retrotrapezoid nucleus (RTN). The key objectives are to: Investigate how persistent expression of wild-type and disease-relevant PHOX2B mutations regulate genes critical...
This $544,924 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the role of the YAP/TAZ signaling pathway in the development of congenital diaphragmatic hernia (CDH)-related lung hypoplasia. The project, led by researchers at The Johns Hopkins University, will utilize mouse models, human lung organoids, and micro-mechanical compression devices to examine how mechanical...
This $915,924 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to investigate how disruptions in early-life microbiome colonization can impact the development and function of lung-resident immune cells and epithelial cells, potentially contributing to respiratory diseases. The research will explore how microbial dysbiosis during infancy reprograms pathways related to lung immunity (resistance) and...